UK markets closed

NIKKEI 225
38,079.70
+117.90(+0.31%)
HANG SENG
16,385.87
+134.03(+0.82%)
CRUDE OIL
82.70
+0.01(+0.01%)
GOLD FUTURES
2,396.30
+7.90(+0.33%)
DOW
37,717.88
-35.43(-0.09%)
Bitcoin GBP
50,690.61
+1,226.04(+2.48%)

Best mortgage deals of the week

As possibility of multiple interest rate cuts dwindle here's what banks and building societies are offering

Nuvectis Pharma, Inc. (NVCT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

6.56

-0.20

(-2.96%)

As of 02:36PM EDT. Market open.

Trade prices are not sourced from all markets

All

Simply Wall St.
Is Nuvectis Pharma (NASDAQ:NVCT) In A Good Position To Deliver On Growth Plans?
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
GlobeNewswire
Nuvectis Pharma's NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines
Highly Synergistic Antiproliferative Activity in EGFR-resistant Cells in Combination with Osimertinib, the Active Ingredient in TagrissoTM Single Agent Antiproliferative Activity in Cells Resistant to Alectinib, the Active Ingredient in AlecensaTM Fort Lee, NJ, April 08, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) today recapped poster highlights from the 2024 American Association for Cancer Research (AACR) conference demonstrating highly synergistic antiproliferative activity
Simply Wall St.
Insider Buys Additional US$51k In Nuvectis Pharma Stock
Whilst it may not be a huge deal, we thought it was good to see that the Nuvectis Pharma, Inc. ( NASDAQ:NVCT...